Argenx Se (ARGX) Total Liabilities (2015 - 2026)

Argenx Se (ARGX) posted quarterly Total Liabilities of $1.6 billion for Q2 2026, up 49.56% year-on-year from $1.1 billion in Q2 2025, and up 18.75% on a QoQ basis from $1.4 billion in Q4 2025.

Argenx Se (ARGX) Total Liabilities (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Total Liabilities for 12 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

  • Quarterly Total Liabilities rose 49.56% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (up 49.56% YoY) and the FY2025 annual result came in at $1.4 billion, up 93.12% from the prior year.
  • Total Liabilities climbed to $1.6 billion in Q2 2026 per ARGX's latest filing, from $1.4 billion in the prior quarter.
  • Over the last five years, Total Liabilities for ARGX reached as high as $1.6 billion in Q2 2026 and fell as low as $279.0 million in Q2 2022.
  • A 5-year average of $741.5 million and a median of $534.3 million in 2024 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2022 — Total Liabilities advanced 1.43% — and 2025, when it soared 102.1%.
  • Year by year, Total Liabilities stood at $320.6 million in 2022, then jumped by 38.8% to $445.0 million in 2023, then surged by 58.27% to $704.2 million in 2024, then soared by 93.12% to $1.4 billion in 2025, then rose by 18.75% to $1.6 billion in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $1.6 billion, $1.4 billion, and $1.1 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 60.46 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 177.22 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 3.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 7.33 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.48 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.62 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 753.82 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 4.05 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.62 Bn
Dec 31, 2025 1.36 Bn
Jun 30, 2025 1.08 Bn
Dec 31, 2024 704.24 Mn
Jun 30, 2024 534.31 Mn
Dec 31, 2023 444.95 Mn
Jun 30, 2023 335.74 Mn
Dec 31, 2022 320.56 Mn
Jun 30, 2022 279.02 Mn
Dec 31, 2021 316.05 Mn
Jun 30, 2021 261.09 Mn
Dec 31, 2020 560.00 Mn
Jun 30, 2020 462.00 Mn
Dec 31, 2019 435.37 Mn
Jun 30, 2019 391.17 Mn
Dec 31, 2018 45.59 Mn
Jun 30, 2018 39.05 Mn
Dec 31, 2017 37.49 Mn
Jun 30, 2017 50.85 Mn
Dec 31, 2016 61.19 Mn